Summary. Thirty-five sexually mature gilts were fed either the compound ICI 33828 (100 mg/day) or a control ration on Day 18 of the oestrous cycle (Day 1 = oestrus). At 2, 4 or 6 days after oestrus, gilts were killed and ovarian and pituitary data collected. Treated gilts not showing an oestrus were killed 10 days after treatment was started. Sixty-seven per cent of the treated gilts showed the forthcoming oestrus. A high percentage (75%) of the treated gilts which exhibited oestrus failed to ovulate. The number of follicles was less than would normally be present before ovulation, and pituitary fsh and lh levels were greater in the ICI 33828-treated (non-ovulating) gilts than in controls. Gilts killed 10 days after initiation of treatment had high levels of pituitary fsh and lh, which may explain the occurrence of superovulation in one gilt (> 100 corpora lutea). These gilts, which did not ovulate except for one pig, also had no follicles greater than 6 mm in diameter, indicating that fsh release was blocked by the drug. The lower ovulation rate in the three ICI 33828-treated gilts which ovulated, compared to the controls, was thought to be the result of decreased follicular growth in the treated gilts.
INTRODUCTION
It has been shown that a high percentage of gilts started on ICI 33828 (an oestrus synchrony drug) during the late follicular phase of the oestrous cycle (Days 18 to 21) will exhibit the forthcoming oestrus (Polge, 1965; Stratman & First, 1965; Garbers & First, 1967) . Based on oestrous cycle lengths, Polge (1965) suggested that some of the gilts exhibiting the forthcoming oestrus when treatment was started during the late follicular phase may not have ovulated or formed active corpora lutea (cl). In the same study, he found two gilts out of 100 that received 100 to 250 mg of ICI 33828/day showing oestrus while under treatment. Neither of these two gilts formed active cl. Garbers & First (1969a) At autopsy, follicle diameters were measured, cl were counted and weighed, uteri were flushed for ova, and follicular fluid and stromal weights were taken. The pituitary glands were collected and immediately frozen at -10°C. The stromal weight was adjusted by co-variance for follicle size by the method described by Short (1967) .
Pituitary lh was estimated by the method of Parlow (1958) and fsh by the method of Steelman & Pohley (1953) . Both methods were modified by the methods described by Short (1967) with the following exceptions. Doses of 0-15, 0-30 and 0-60 mg dry pituitary powder were used in a three-dose (two rat/dose) assay for lh. In the HCG-synergism (hcg-s) bio-assay for fsh, doses of 2 and 4 mg of pituitary powder from ICI 33828-treated gilts and 4 and 8 mg from control gilts were used. nih-lh-s11 and nih-fsh-s4 standards were also run at 0-4, 0-8 and 1-6 µg and 60 and 120 /ig respectively. Because of unequal subclass numbers, the overall assay regression was tested against the standard regression by the method of Steel & Torrie (1960 Finney (1964) . Least Table 3 , superovulated and had more than eighty ova in the upper uterus. A superovulation has also been reported after treatment-withdrawal by Polge (1965) .
A tendency for a Day 2+4 versus Day 6xtreatment interaction (P<0-1) existed in the analysis of follicular fluid weight. The controls increased in (1) Less follicular development occurred in treated gilts and therefore higher fsh levels were present. This was due to inhibition of some fsh release by the ICI 33828 compound.
(2) When ovulation occurred in ICI 33828-treated gilts, the ovulation rate was less due to the reduction in follicle growth.
The significant Day 2+4 versus Day 6 treatment interaction in the analysis of fsh levels can also be explained. Anderson (1966) fits the data. The numbers of follicles <4 mm and 4 to 7 mm in diameter in the treated gilts, however, increased to equal those of the controls. Another problem associated with the hypothesis is the mechanism by which the follicles formed at oestrus were maintained. Although the controls increased in follicular fluid weight between Days 4 and 6 and the ICI 33828-treated gilts did not, the absolute value of follicular fluid weight was still greater in the treated gilts. If these follicles require fsh, and if the growth of small follicles is indicative of the presence of fsh, the effect of the ICI 33828 compound was to enhance fsh synthesis. The theory of increased fsh synthesis due to the ICI 33828 compound seems unreasonable, since Brown (1963) has shown decreased fsh production in the rat, and follicle development in the cycling pig is suppressed by the drug (Polge, 1965; Stratman & First, 1965) . The suppression of follicle growth at Day 10, except in the one pig which superovulated, and the high levels of pituitary fsh at Day 10, support the hypothesis that the ICI 33828 compound blocks lh and fsh release, but not their synthesis (Garbers & First, 1969b 
